Domain Informations
Phesgo-hcp.com lookup results from whois.safenames.net server:
- Domain created: 2020-04-16T18:24:22Z
- Domain updated: 2024-05-01T03:07:13Z
- Domain expires: 2026-04-16T18:24:22Z 1 Year, 205 Days left
- Website age: 4 Years, 159 Days
- Registrar Domain ID: 2515467663_DOMAIN_COM-VRSN
- Registrar Url: http://www.safenames.net
- Registrar WHOIS Server: whois.safenames.net
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: +44.1908200022
- Name server:
- ALAN.NS.CLOUDFLARE.COM
- LARA.NS.CLOUDFLARE.COM
Network
- inetnum : 104.16.0.0 - 104.31.255.255
- name : CLOUDFLARENET
- handle : NET-104-16-0-0-1
- status : Direct Allocation
- created : 2010-07-09
- changed : 2021-07-01
- desc : All Cloudflare abuse reporting can be done via https://www.cloudflare.com/abuse,Geofeed: https://api.cloudflare.com/local-ip-ranges.csv
Owner
- organization : Cloudflare, Inc.
- handle : CLOUD14
- address : Array,San Francisco,CA,94107,US
Technical support
- handle : ADMIN2521-ARIN
- name : Admin
- phone : +1-650-319-8930
- email : [email protected]
Abuse
- handle : ABUSE2916-ARIN
- name : Abuse
- phone : +1-650-319-8930
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 104.18.16.192
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Site Inspections
Port Scanner (IP: 104.18.16.192)
Spam Check (IP: 104.18.16.192)
Recent Searched Sites
› Draftguru.com.au (1 mins ago) / CN
› Togel4d-login68742.mpeblog.com (27 seconds ago) / US
› Peregrineseniorliving.com (1 mins ago) / US
› Percorsols.com (1 mins ago) / US
› Articulo66.com (13 seconds ago) / US
› Lionel-charles-jeffries.journal-of-life.com (35 seconds ago) / FR
› Thefrugalnoodle.com (1 mins ago) / US
› Participatorymethods.org (14 seconds ago) / GB
› Phenion.com (18 seconds ago) / DE
› Phenomenex.com (11 seconds ago) / US
› Arsenalmastera.ru (23 seconds ago) / DE
› Pheonixindustries.com (5 seconds ago) / IN
› Undrctrl.id (6 seconds ago) / US
› Causebox.com (21 seconds ago) / US
› Calstatedistributing.com (38 seconds ago) / US
› Phenixski.com (13 seconds ago) / JP
› Perniknews.com (41 seconds ago) / US
› Phesgo-hcp.com (1 seconds ago) / US
› Wowamazing.com (4 seconds ago) / BG
› 11.14 (3 seconds ago) / US
Websites Listing
We found Websites Listing below when search with phesgo-hcp.com on Search Engine
Contact a Representative | PHESGO® (pertuzumab / …
If PHESGO is administered during pregnancy, or if a patient becomes pregnant while receiving PHESGO or within 7 months following the last dose of PHESGO, health care providers and patients should immediately report PHESGO exposure to Genentech at 1-888-835-2555. Pulmonary Toxicity PHESGO can cause serious and fatal pulmonary toxicity. These ...
Phesgo-hcp.comHCP Forms & Documents | PHESGO® (pertuzumab / trastuzumab ...
If PHESGO is administered during pregnancy, or if a patient becomes pregnant while receiving PHESGO or within 7 months following the last dose of PHESGO, health care providers and patients should immediately report PHESGO exposure to Genentech at 1-888-835-2555. Pulmonary Toxicity PHESGO can cause serious and fatal pulmonary toxicity. These ...
Phesgo-hcp.comSign up for PHESGO updates - phesgo-hcp.com
If PHESGO is administered during pregnancy, or if a patient becomes pregnant while receiving PHESGO or within 7 months following the last dose of PHESGO, health care providers and patients should immediately report PHESGO exposure to Genentech at 1-888-835-2555. Pulmonary Toxicity PHESGO can cause serious and fatal pulmonary toxicity. These ...
Phesgo-hcp.comHelpful links for patients - phesgo-hcp.com
If PHESGO is administered during pregnancy, or if a patient becomes pregnant while receiving PHESGO or within 7 months following the last dose of PHESGO, health care providers and patients should immediately report PHESGO exposure to Genentech at 1-888-835-2555. Pulmonary Toxicity PHESGO can cause serious and fatal pulmonary toxicity. These ...
Phesgo-hcp.comPHESGO® (pertuzumab / trastuzumab / hyaluronidase …
If PHESGO is administered during pregnancy, or if a patient becomes pregnant while receiving PHESGO or within 7 months following the last dose of PHESGO, health care providers and patients should immediately report PHESGO exposure to Genentech at 1-888-835-2555. Pulmonary Toxicity PHESGO can cause serious and fatal pulmonary toxicity. These ...
Phesgo-hcp.comImportant Safety Information | PHESGO® (pertuzumab / …
If PHESGO is administered during pregnancy, or if a patient becomes pregnant while receiving PHESGO or within 7 months following the last dose of PHESGO, health care providers and patients should immediately report PHESGO exposure to Genentech at 1-888-835-2555. Pulmonary Toxicity PHESGO can cause serious and fatal pulmonary toxicity. These ...
Phesgo-hcp.comPatient Financial FAQs | PHESGO® (pertuzumab / trastuzumab ...
If PHESGO is administered during pregnancy, or if a patient becomes pregnant while receiving PHESGO or within 7 months following the last dose of PHESGO, health care providers and patients should immediately report PHESGO exposure to Genentech at 1-888-835-2555. Pulmonary Toxicity PHESGO can cause serious and fatal pulmonary toxicity. These ...
Phesgo-hcp.comQuestions For Your Care Team | PHESGO®
Taking an active role in your care is important. You are an integral part of your healthcare team, and that means you can speak up, get involved, and work together to make a plan for treatment that feels right for both you and your care team. The most important first step is asking questions. This can help you set goals together and be more ...
Phesgo.comDear Healthcare Professional, - hossnextwave.com
If you have questions or would like more information about PHESGO, please email Genentech at [email protected]. Contraindications PHESGO is contraindicated in patients with known hypersensitivity to pertuzumab, or trastuzumab, or hyaluronidase, or to any of its excipients. Additional Important Safety Information Cardiomyopathy and Cardiac Monitoring • PHESGO …
Hossnextwave.comFeDeriCa & PHranceSCa Clinical Trial Results - phesgo
If PHESGO is administered during pregnancy, or if a patient becomes pregnant while receiving PHESGO or within 7 months following the last dose of PHESGO, health care providers and patients should immediately report PHESGO exposure to Genentech at 1-888-835-2555. Pulmonary Toxicity PHESGO can cause serious and fatal pulmonary toxicity. These ...
Phesgo-hcp.comPHESGO Access Solutions Patient Support | PHESGO™ …
PHESGO™ (pertuzumab, trastuzumab, and hyaluronidase-zzxf) My Patient Solutions® Login Log in to My Patient Solutions® Call (877) 436-3683 Call (877) 436-3683
Genentech-access.comSubmit, Print or Download PHESGO Forms & Documents| PHESGO …
Download, view or print PHESGO Access Solutions enrollment forms and other important documents. Submit enrollment forms online. Find sample letters of medical necessity and sample appeal letters. Skip To Main Content . US Patient Site. PHESGO™ (pertuzumab, trastuzumab, and hyaluronidase-zzxf) My Patient Solutions® Login Log in to My Patient Solutions® Call …
Genentech-access.comPhesgo (pertuzumab trastuzumab hyaluronidase) - Roche
Phesgo can be administered by a healthcare professional in a treatment centre or at a patient’s home. Phesgo is approved with the same indications as IV Perjeta in many regions worldwide, including EU countries and the US. This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals and patients …
Roche.comPertuzumab, Trastuzumab, and Hyaluronidase (Phesgo) - Chemocare
The following symptoms require medical attention, but are not an emergency. Contact your health care provider within 24 hours of noticing any of the following: Nausea (interferes with ability to eat and unrelieved with prescribed medication) Vomiting (vomiting more than 4-5 times in a 24-hour period) Diarrhea (4-6 episodes in a 24-hour period)
Chemocare.comWriting an email to an HCP. - Hexagone
2021-02-11 · 5. Calls to action. That is the first HCP engagement sign driven by an email so it is important to make the right choice and insert it the right place. Always keeping in mind that they should add value to your communication. One of the most recommended ones are the ones that are also seen as a provided service:
Hexagone.lifePHESGO Access Solutions | PHESGO™ (pertuzumab, trastuzumab, …
PHESGO™ (pertuzumab, trastuzumab, and hyaluronidase-zzxf) POLIVY® (polatuzumab vedotin-piiq) PULMOZYME® (dornase alfa) Inhalation Solution; RITUXAN® (rituximab) RITUXAN HYCELA® (rituximab/hyaluronidase human) SUSVIMO™ (ranibizumab injection) ROZLYTREK® (entrectinib) TECENTRIQ® (atezolizumab) VABYSMO™ (faricimab-svoa)
Genentech-access.comDownload Helpful Resources for Your Practice | Genentech Access …
PHESGO™ (pertuzumab, trastuzumab, and hyaluronidase-zzxf) My Patient Solutions® Login Log in to My Patient Solutions® Call (877) 436-3683 Call (877) 436-3683
Genentech-access.comPHESGO™ (pertuzumab/trastuzumab/hyaluronidase-zzfx)
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control.
Genentech-pro.comPhesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf
2020-10-13 · If PHESGO is administered during pregnancy, or if a patient becomes pregnant while receiving PHESGO or within 7 months following the last dose of PHESGO, health care providers and patients should immediately report PHESGO exposure to Genentech at 1-888-835-2555. Risk Summary. PHESGO can cause fetal harm when administered to a pregnant …
Rxlist.comHow PHESGO is thought to work
If you are exposed to PHESGO during pregnancy, or become pregnant while receiving PHESGO or within 7 months following the last dose of PHESGO, you are encouraged to report PHESGO exposure to Genentech at 1-888-835-2555. PHESGO may cause serious lung problems. Your doctor may check for signs of lung problems including: Severe shortness of breath.
Phesgo.com
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| machtvillage.com | godaddy.com | -1 Years, -331 Days |
| mentalab.com | godaddy.com | 139 Days |
| fire22.ag | gandi.net | -1 Years, -340 Days |
| youdontreadcomics.com | tucows.com | -1 Years, -237 Days |
| tadri.org | publicdomainregistry.com | 235 Days |
| vibeable.io | namecheap.com | -2 Years, -158 Days |
| newsctrls.com | namecheap.com | -2 Years, -21 Days |
| zjabhw.com | net.cn | -2 Years, -200 Days |
| hunyl.com | dnspod.cn | 3 Years, 119 Days |
| form-ly.com | godaddy.com | -2 Years, -141 Days |